BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10604963)

  • 1. Effect of gender on anti-inflammatory and analgesic actions of two kappa-opioids.
    Binder W; Carmody J; Walker J
    J Pharmacol Exp Ther; 2000 Jan; 292(1):303-9. PubMed ID: 10604963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the peripherally selective kappa-opioid agonist, asimadoline, on adjuvant arthritis.
    Binder W; Walker JS
    Br J Pharmacol; 1998 Jun; 124(4):647-54. PubMed ID: 9690855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the peripherally selective kappa-opioid asimadoline, on substance P and CGRP mRNA expression in chronic arthritis of the rat.
    Walker JS; Scott C; Bush KA; Kirkham BW
    Neuropeptides; 2000; 34(3-4):193-202. PubMed ID: 11021980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory effects of contralateral administration of the kappa-opioid agonist U-50,488H in rats with unilaterally induced adjuvant arthritis.
    Bileviciute-Ljungar I; Saxne T; Spetea M
    Rheumatology (Oxford); 2006 Mar; 45(3):295-302. PubMed ID: 16249243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex and rat strain determine sensitivity to kappa opioid-induced antinociception.
    Barrett AC; Cook CD; Terner JM; Roach EL; Syvanthong C; Picker MJ
    Psychopharmacology (Berl); 2002 Mar; 160(2):170-81. PubMed ID: 11875635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans.
    Machelska H; Pflüger M; Weber W; Piranvisseh-Völk M; Daubert JD; Dehaven R; Stein C
    J Pharmacol Exp Ther; 1999 Jul; 290(1):354-61. PubMed ID: 10381799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contralateral, ipsilateral and bilateral treatments with the kappa-opioid receptor agonist U-50,488H in mononeuropathic rats.
    Bileviciute-Ljungar I; Spetea M
    Eur J Pharmacol; 2004 Jun; 494(2-3):139-46. PubMed ID: 15212967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of substance P in the anti-inflammatory effects of the peripherally selective kappa-opioid asimadoline and the NK1 antagonist GR205171.
    Binder W; Scott C; Walker JS
    Eur J Neurosci; 1999 Jun; 11(6):2065-72. PubMed ID: 10336675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nociceptive sensitivity and opioid antinociception and antihyperalgesia in Freund's adjuvant-induced arthritic male and female rats.
    Cook CD; Nickerson MD
    J Pharmacol Exp Ther; 2005 Apr; 313(1):449-59. PubMed ID: 15608071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the antinociceptive effect of oxycodone in male and female rats.
    Holtman JR; Wala EP
    Pharmacol Biochem Behav; 2006 Jan; 83(1):100-8. PubMed ID: 16434089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of gonadal steroid hormone treatments on opioid antinociception in ovariectomized rhesus monkeys.
    Negus SS; Mello NK
    Psychopharmacology (Berl); 2002 Jan; 159(3):275-83. PubMed ID: 11862360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of the hypothalamo-hypophyseal-adrenal axis to the anti-inflammatory actions of the kappa-opioid agonist PNU-50,488H in rats with adjuvant arthritis.
    Wilson JL; Carmody JJ; Walker JS
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1131-6. PubMed ID: 10945869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinociceptive and adverse effects of mu- and kappa-opioid receptor agonists: a comparison of morphine and U50488-H.
    Gallantine EL; Meert TF
    Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):419-27. PubMed ID: 18699797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The individual and combined effects of U50,488, and flurbiprofen axetil on visceral pain in conscious rats.
    Kitamura T; Ogawa M; Yamada Y
    Anesth Analg; 2009 Jun; 108(6):1964-6. PubMed ID: 19448232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
    Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of NMDA antagonists and an alpha 2 agonist with mu, delta and kappa opioids in an acute nociception assay.
    Baker AK; Hoffmann VL; Meert TF
    Acta Anaesthesiol Belg; 2002; 53(3):203-12. PubMed ID: 12461830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mu-Opioid agonists inhibit the enhanced intracellular Ca(2+) responses in inflammatory activated astrocytes co-cultured with brain endothelial cells.
    Hansson E; Westerlund A; Björklund U; Olsson T
    Neuroscience; 2008 Sep; 155(4):1237-49. PubMed ID: 18692967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory effects of opioids.
    Walker JS
    Adv Exp Med Biol; 2003; 521():148-60. PubMed ID: 12617572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory effects of kappa-opioids in adjuvant arthritis.
    Walker JS; Howlett CR; Nayanar V
    Life Sci; 1995; 57(4):371-8. PubMed ID: 7603309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation-susceptible Lewis rats show less sensitivity than resistant Fischer rats in the formalin inflammatory pain test and with repeated thermal testing.
    Lariviere WR; Sattar MA; Melzack R
    J Neurophysiol; 2006 May; 95(5):2889-97. PubMed ID: 16452262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.